体外冲击波碎石术治疗泌尿系结石的效果分析

Effect analysis of extracorporeal shock wave lithotripsy in the treatment of urinary calculi

目的 分析体外冲击波碎石术治疗泌尿系结石的临床效果。方法 84例泌尿系结石患者,随机将其分为对照组与观察组,每组42例。对照组给予外科微创经皮肾镜取石术,观察组采用体外冲击波碎石术。比较两组临床疗效、并发症发生率、出院6个月内复发率、住院时间、治疗费用。结果 观察组治疗总有效率90.48%高于对照组的73.81%,差异具有统计学意义(P<0.05)。观察组并发症发生率4.76%、复发率2.38%均低于对照组的23.81%、21.43%,差异均具有统计学意义(P<0.05)。观察组住院时间短于对照组,治疗费用低于对照组,差异具有统计学意义(P<0.05)。结论 体外冲击波碎石术在治疗泌尿系结石方面具有较高的安全性、操作流程简单等优势,同时联合辅助药物进行治疗,使结石碎石效果与排清率进行提高,值得在临床中进行广泛推广。

Objective To analyze the clinical effect of extracorporeal shock wave lithotripsy in the treatment of urinary calculi. Methods A total of 84 patients with urinary calculi were randomly divided into control group and observation group, with 42 cases in each group. The control group was treated with minimally invasive percutaneous nephrolithotomy, and the observation group was treated with extracorporeal shock wave lithotripsy. The clinical efficacy, complication rate, recurrence rate within 6 months after discharge, hospitalization time, and treatment cost were compared between the two groups. Results The total effective rate 90.48% of the observation group was higher than 73.81% of the control group, and the difference was statistically significant(P<0.05). The complication rate of the observation group was 4.76% and the recurrence rate was 2.38%, which were lower than 23.81% and 21.43% of the control group, and the differences were statistically significant(P<0.05).The hospitalization time of the observation group was shorter than that of the control group, and the treatment cost was lower than that of the control group. All the differences were statistically significant(P<0.05). Conclusion Extracorporeal shock wave lithotripsy has the advantages of high safety and simple operation procedure in the treatment of urinary calculi can effectively improve the treatment satisfaction of patients with high safety, simple operation process and other advantages. At the same time, adjuvant drug treatment can improve the calculi crushing effect and clearance rate, which is worthy of widespread clinical promotion.